GlassScriptPhysician profile
Janet D Conway
NPI 1427009901
$46,427.12
in general payments reported to CMS, 2019-2025
36 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,683 · 2020: $5,151 · 2021: $12K · 2022: $3,866 · 2023: $6,192 · 2024: $9,464 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $2,537 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,941.25 |
| Food and Beverage | $2,537.31 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $15,551.38 | 2021-2023 | Truelok |
| Medical Device Business Services, INC. | $9,234.21 | 2022-2024 | Tomofix |
| Smith+Nephew, INC. | $9,002.61 | 2019-2025 | Oasis, Grafix Pl, Stravix Mesh |
| Bone Support INC. | $7,706.86 | 2019-2024 | Cerament G, Ceramentbone Void Filler |
| Zimmer Biomet Holdings, INC. | $1,419.58 | 2019-2023 | Archimis |
| Synthes Gmbh | $1,000.00 | 2024-2025 | |
| Abbvie INC. | $599.47 | 2021-2025 | Teflaro, Dalvance |
| Biocomposites INC | $244.03 | 2019-2025 | Stimulan |
| Depuy Synthes Sales INC. | $197.76 | 2020-2023 | Vivigen Mis Delivery System, Na |
| Globus Medical, INC. | $173.09 | 2025 | Precice® Intramedullary Limb Lengthening System, Actify 3d |
| C. R. Bard, INC. & Subsidiaries | $163.65 | 2023 | Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $143.75 | 2020-2022 | |
| Melinta Therapeutics, LLC | $124.74 | 2024-2025 | Rezzayo, Orbactiv, Kimyrsa |
| Nevro Corp. | $111.15 | 2021 | |
| Baxter Healthcare | $94.69 | 2023-2025 | Artiss |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $81.84 | 2021-2025 | Nuzyra |
| Bioventus LLC | $52.79 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Kyowa Kirin, INC. | $48.47 | 2024 | Crysvita |
| Dynasplint Systems INC. | $47.10 | 2019 | |
| Solventum Corporation | $45.64 | 2024-2025 | Activ.A.C. |
| Avita Medical Americas, LLC | $37.87 | 2024-2025 | Recell, Cohealyx, Permeaderm |
| Vertex Pharmaceuticals Incorporated | $36.17 | 2025 | |
| Si-Bone, INC. | $33.30 | 2020 | |
| Organogenesis INC. | $32.79 | 2025 | Puraply Wound Matrix |
| Ethicon US, LLC | $29.85 | 2023 | Stratafix, Ethicon, Vistaseal |
| Allergan, INC. | $28.82 | 2019-2020 | |
| Integra Lifesciences Corporation | $28.43 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $27.00 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Supreme Orthopedic Systems, LLC | $24.17 | 2023 | |
| Deroyal Industries, INC. | $20.79 | 2019 | |
| Acell, INC. | $19.13 | 2019 | |
| Cerapedics INC. | $16.61 | 2021 | |
| Convatec INC. | $15.18 | 2024 | |
| Heraeus Medical, LLC. | $14.13 | 2019 | |
| Zimvie INC. | $12.44 | 2022 | |
| Illuminoss Medical, INC. | $7.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.